Evidence map›Paper›PMID 25573592›Full record

ArticlePathology oncology research : POR2015

Functional variants of lipid level modifier MLXIPL, GCKR, GALNT2, CILP2, ANGPTL3 and TRIB1 genes in healthy Roma and Hungarian populations.

Katalin Sumegi, Luca Jaromi, Lili Magyari, Erzsebet Kovesdi, Balazs Duga, Renata Szalai, Anita Maasz, Petra Matyas, Ingrid Janicsek, Bela Melegh

Abstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. ANGPLT3 in cardio-metabolic disorders.Molecular biology reports · 2021
    Review
  5. Review
  6. Article
  7. Article
  8. Association study of genetic variants of theNeuropsychiatric disease and treatment · 2019
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Katalin SumegiDepartment of Medical Genetics, Clinical Centre, University of Pecs, Szigeti u. 12, Pecs, H-7624, Hungary, sumegi.katalin@pte.hu.
Luca Jaromi
Lili Magyari
Erzsebet Kovesdi
Balazs Duga
Renata Szalai
Anita Maasz
Petra Matyas
Ingrid Janicsek
Bela Melegh
University of Pecs · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of triglyceride metabolism in different diseases, such as cardiovascular or cerebrovascular diseases is still under extensive investigations. In genome-wide studies several polymorphisms have been reported, which are highly associated with plasma lipid level changes. Our goal was to examine eight variants: rs12130333 at the ANGPTL3, rs16996148 at the CILP2, rs17321515 at the TRIB1, rs17145738 and rs3812316 of the MLXIPL, rs4846914 at GALNT2, rs1260326 and rs780094 residing at the GCKR loci. A total of 399 Roma (Gypsy) and 404 Hungarian population samples were genotyped using PCR-RFLP method. Significant differences were found between Roma and Hungarian population samples in both MLXIPL variants (C allele frequency of rs17145738: 94.1% vs. 85.6%, C allele frequency of rs3812316: 94.2% vs. 86.8% in Romas vs. in Hungarians, p < 0.05), in ANGPTL3 (T allele frequency of rs1213033: 12.2% vs. 18.5% in Romas vs. Hungarians, p < 0.05) and GALNT2 (G allele frequency of rs4846914: 46.6% vs. 54.5% Romas vs. in Hungarians, p < 0.05), while no differences over SNPs could be verified and the known minor alleles showed no correlation with triglyceride levels in any population samples. The current study revealed fundamental differences of known triglyceride modifying SNPs in Roma population. Failure of finding evidence for affected triglyceride metabolism shows that these susceptibility genes are much less effective compared for example to the apolipoprotein A5 gene.

Indexed as

Adaptor Proteins, Signal TransducingAngiopoietin-Like Protein 3Angiopoietin-like ProteinsAngiopoietinsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBiomarkersEthnicityFemaleGene FrequencyGenotypeHumansHungaryIntracellular Signaling Peptides and ProteinsMaleMicrotubule-Associated ProteinsMiddle AgedAdaptor Proteins, Signal TransducingAngiopoietin-Like Protein 3Angiopoietin-like ProteinsAngiopoietinsANGPTL3 protein, humanBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBiomarkerscytoplasmic linker protein 115GCKR protein, humanIntracellular Signaling Peptides and ProteinsMicrotubule-Associated ProteinsMLXIPL protein, humanN-AcetylgalactosaminyltransferasesPolypeptide N-acetylgalactosaminyltransferaseProtein Serine-Threonine KinasesTRIB1 protein, humanTriglycerides

Identifiers

PMID25573592
OpenAlexW1985934387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.